US FDA’s Byooviz Review By The Numbers

 
• By Sue Sutter
  
Drug Review Profile: Byooviz Chronology
Byooviz was the first biosimilar to Lucentis approved in the US. • Source: Shutterstock/Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics